DUBLIN and ATLANTA, April 7, 2024 /7Newswire — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), were presented as a late breaking clinical trial at the American College of Cardiology Annual Scientific Session and simultaneously published in The New …

Continue reading “SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women”

CARLSBAD, Calif., April 7, 2024 /7Newswire — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced full results from the Phase 3 Balance study of Ionis’ lead independent investigational medicine, olezarsen, for the treatment of adults with familial chylomicronemia syndrome (FCS). The olezarsen 80 mg monthly dose met the primary endpoint of significantly reducing triglycerides (TGs) in patients with genetically …

Continue reading “Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome”

NEW YORK, April 6, 2024 /7Newswire — Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24-cv-02613, is on behalf of a class consisting …

Continue reading “Pomerantz Law Firm Announces the Filing of a Class Action Against Checkpoint Therapeutics, Inc. and Certain Officers – CKPT”

NASSAU, Bahamas, April 6, 2024 /7Newswire — OKX, a leading crypto exchange and Web3 technology company, has issued updates for April 6, 2024. OKX Announces Adjustments to Position Tiers of Several Futures Contracts OKX today announced that it will adjust the position tiers of several futures contracts between 8:00 am and 10:00 am UTC on April 11, 2024. The adjustments will affect several …

Continue reading “Flash News: OKX Announces Adjustments to Position Tiers of Several Futures Contracts”

NEW YORK, April 6, 2024 /7Newswire — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Innodata Inc. (NASDAQ: INOD) between May 9, 2019 and February 14, 2024, both dates inclusive (the “Class Period”), of the important April 22, 2024 lead plaintiff deadline. SO WHAT: If you purchased Innodata common stock during the Class Period you may …

Continue reading “ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Innodata Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INOD”